Clinical trial using magic mushrooms to treat depression gets go-ahead from FDA
 |
(Natural News) The FDA has just granted U.S. approval to a life sciences startup in London to use the psychedelic ingredient found in magic mushrooms in a trial for treating depression. The startup, Compass Pathways, was launched just two years ago with the backing of Peter Thiel. The trial is a phase IIB study of… |
>View original article
Author:
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.